3-year relapse-free survival (RFS), overall survival (OS) and long-term toxicity of (neo)adjuvant ipilimumab (IPI) + nivolumab (NIVO) in macroscopic stage III melanoma (OpACIN trial)
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Harm van Tinteren |
| Publication date | October 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://linkinghub.elsevier.com/retrieve/pii/S0923753419595242 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |